Partner Content

How serialization will shape the future of the pharma industry

Q: What are the key challenges facing the pharmaceutical industry when it comes to implementing serialization regulations?From a technological standpoint,…

How CATs can enhance clinical trials

PROMs are composed of a fixed number of items – that is, a question and its associated response scale. While…

Outsourcing trends in clinical trials: How one company is reimagining the FSP model

Full-service outsourcing has traditionally ruled the roost in the clinical world, but increased competition from functional service providers (FSPs) has…

Host-Cell Protein Analytics: History and Future Trends

Different analytical methods have been developed to detect host-cell proteins (HCPs) in bioprocess streams. Advancements in such methods are enabling…

No more cookies: How healthcare companies can gain trust for data consent

Data is a valuable commodity in an age of data-driven marketing, but considerable care must be taken when collecting sensitive…

Improving health equity in Europe’s small countries: How can we remove the barriers to access?

When it comes to health equity, the citizens of smaller countries in Europe can sometimes be at a disadvantage. According…

Launching pharmaceuticals in the Nordics: Opportunities and challenges

The Nordic countries have it all. From beautiful landscapes lit by the northern lights to world-class living standards and generous…

Clinical trials: How AI can help providers stay TMF inspection-ready

The clinical trials landscape is evolving quickly. Delivery of clinical research has changed as the industry has faced myriad challenges,…

Does AI/ML make CROs obsolete? It depends…

One of the many luxuries of working in an industry for a long time is that you get to witness…

How a flexible FSP model fills the talent gap

There is continuous evaluation and varying opinion regarding the strategic resourcing models employed within the biopharmaceutical sector today.  Notwithstanding the…